Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genoil (GNOLF) EBITDA (2018 - 2025)

Genoil has reported EBITDA over the past 8 years, most recently at -$147005.0 for Q3 2025.

  • Quarterly EBITDA fell 5.62% to -$147005.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Sep 2025, down 27.2% year-over-year, with the annual reading at -$2.0 million for FY2024, 45.05% up from the prior year.
  • EBITDA was -$147005.0 for Q3 2025 at Genoil, up from -$213951.0 in the prior quarter.
  • Over five years, EBITDA peaked at -$104359.0 in Q4 2021 and troughed at -$2.2 million in Q1 2023.
  • The 5-year median for EBITDA is -$169551.0 (2022), against an average of -$455711.5.
  • Year-over-year, EBITDA tumbled 711.64% in 2023 and then soared 93.76% in 2024.
  • A 5-year view of EBITDA shows it stood at -$104359.0 in 2021, then plummeted by 36.84% to -$142801.0 in 2022, then tumbled by 711.64% to -$1.2 million in 2023, then tumbled by 33.71% to -$1.5 million in 2024, then surged by 90.51% to -$147005.0 in 2025.
  • Per Business Quant, the three most recent readings for GNOLF's EBITDA are -$147005.0 (Q3 2025), -$213951.0 (Q2 2025), and -$147506.0 (Q1 2025).